Sponsor:
University of Chicago
Code:
NCT02333162
Conditions
Previously Treated Myelodysplastic Syndrome
Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Adult Acute Myeloid Leukemia
Recurrent Hematologic Malignancy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Fludarabine Phosphate
Melphalan
Intensity-Modulated Radiation Therapy
Total Marrow Irradiation
Allogeneic Hematopoietic Stem Cell Transplantation
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by University of Chicago on 2025-02-05.